DCM
RMD icon

Donaldson Capital Management’s ResMed RMD Stock Holding History

Donaldson Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,902
Closed -$461K – 246
2022
Q1 		$461K Sell
1,902
-538
-22% -$130K 0.02% 182
2021
Q4 		$635K Sell
2,440
-205
-8% -$53.2K 0.03% 161
2021
Q3 		$697K Sell
2,645
-79
-3% -$21.6K 0.04% 144
2021
Q2 		$672K Sell
2,724
-301
-10% -$63.3K 0.03% 141
2021
Q1 		$587K Sell
3,025
-6
-0.2% -$1.2K 0.03% 155
2020
Q4 		$644K Sell
3,031
-64
-2% -$12.8K 0.04% 131
2020
Q3 		$531K Sell
3,095
-559
-15% -$103K 0.04% 136
2020
Q2 		$702K Buy
3,654
+769
+27% +$126K 0.05% 103
2020
Q1 		$425K Buy
+2,885
New +$460K 0.04% 129

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Donaldson Capital Management's RMD Position: Q2 2022 in Review

Donaldson Capital Management sold out of ResMed (RMD) in Q2 2022, closing a stake of 1,902 shares — an estimated $461K sold.

Donaldson Capital Management first reported a position in RMD in Q1 2020 and held it in 9 quarters. The position peaked at $702K in Q2 2020. 676 funds tracked by Wall St. Rank hold RMD as of Q2 2022.

  • Donaldson Capital Management reported no remaining ResMed position as of Q2 2022 after selling out during the quarter.
  • Donaldson Capital Management sold 1,902 ResMed shares in Q2 2022, an estimated $461K.
  • Donaldson Capital Management first reported a position in ResMed in Q1 2020 and held it in 9 quarters.
  • Donaldson Capital Management's ResMed position peaked at $702K in Q2 2020.
  • 676 funds tracked by Wall St. Rank held ResMed as of Q2 2022.

Based on Donaldson Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.